SCHEMBL30699763

SCHEMBL30699763

Oc1nc(O)c2c(F)c(F)cc(F)c2n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30699839 0.81 — —
SCHEMBL31412243 0.81 — —
SCHEMBL31491019 0.73 — —
SCHEMBL24820532 0.72 — —
SCHEMBL30803661 0.69 ERN1 (0.35) —
SCHEMBL29680010 0.68 — —
SCHEMBL38659228 0.67 PARP1 (0.34) —
SCHEMBL22029150 0.64 — —
SCHEMBL29071028 0.64 — —
SCHEMBL1586293 0.64 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023244713-A1 QUINAZOLINE DERIVATIVES, COMPOSITIONS AND METHODS THEREOF ENSEM THERAPEUTICS, INC. (US) 2023-12-21 — — WO disclosed
Send feedback